Cerebral Venous Sinus Thrombosis During Raloxifene Therapy: A Case Report

A 79-year-old woman taking raloxifene for osteoporosis was admitted to our hospital with right-sided hemiplegia and seizures. Computed tomography (CT) of the head revealed a subcortical hemorrhage in the left frontal to parietal lobes. CT venography (CTV) showed a disruption of the superior sagittal sinus, leading to a diagnosis of cerebral venous sinus thrombosis (CVST). In the absence of other thrombogenic factors, raloxifene was considered a potential contributing factor. She received continuous intravenous heparin followed by warfarin, without clinical deterioration, and was later transferred to a rehabilitation hospital. Although venous thrombosis is a recognized adverse effect of raloxifene, CVST remains an uncommon manifestation. We therefore present this case to highlight the potential association.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-06-06
DOI
https://doi.org/10.7759/cureus.85486
Primary Topic
Cerebral Venous Sinus Thrombosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cerebral Venous Sinus Thrombosis During Raloxifene Therapy: A Case Report

Tadataka Mizoguchi, Takahiro Kuwashiro, Yusuke Imamura, Naoki Tagawa et al.
Cureus
Cerebral Venous Sinus Thrombosis
article

Cerebral Venous Sinus Thrombosis During Raloxifene Therapy: A Case Report

Tadataka Mizoguchi, Takahiro Kuwashiro, Yusuke Imamura, Naoki Tagawa, Hiroshi Sugimori, Shunsuke Kimura, Kota Mori
article en

Abstract

A 79-year-old woman taking raloxifene for osteoporosis was admitted to our hospital with right-sided hemiplegia and seizures. Computed tomography (CT) of the head revealed a subcortical hemorrhage in the left frontal to parietal lobes. CT venography (CTV) showed a disruption of the superior sagittal sinus, leading to a diagnosis of cerebral venous sinus thrombosis (CVST). In the absence of other thrombogenic factors, raloxifene was considered a potential contributing factor. She received continuous intravenous heparin followed by warfarin, without clinical deterioration, and was later transferred to a rehabilitation hospital. Although venous thrombosis is a recognized adverse effect of raloxifene, CVST remains an uncommon manifestation. We therefore present this case to highlight the potential association.

CureusVol. 17(6)
National Kyushu Medical Center (JP)
Good health and well-being
Openalex Percentile: Top 79%
Cerebral Venous Sinus Thrombosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.